NCT02134925View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 23, 2014

Primary Completion Date

January 27, 2017

Study Completion Date

March 6, 2026

Conditions
Colorectal AdenomaColorectal Adenoma With Severe DysplasiaColorectal CarcinomaColorectal Tubulovillous Adenoma
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

MUC1 Peptide-Poly-ICLC Vaccine

Given SC

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Saline

Given SC

Trial Locations (7)

15232

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh

19107

Thomas Jefferson University Hospital, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

55905

Mayo Clinic in Rochester, Rochester

64128

Kansas City Veterans Affairs Medical Center, Kansas City

02114

Massachusetts General Hospital Cancer Center, Boston

00936

University of Puerto Rico, San Juan

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH